Hepatic lipid accumulation, mainly in the form of triglycerides (TGs), is the hallmark of non-alcoholic fatty liver disease (NAFLD). To date, the spatial distribution of individual lipids in NAFLD-affected livers is not well characterized. This study aims to map the triglyceride distribution in normal human liver samples and livers with NAFLD and cirrhosis with imaging mass spectrometry (MALDI IMS). Specifically, whether individual triglyceride species differing by fatty acid chain length and degree of saturation correlate with the histopathological features of NAFLD as identified with classical H&E. Using a recently reported sodium-doped gold-assisted laser desorption/ionization IMS sample preparation, 20 human liver samples (five normal livers, five samples with simple steatosis, five samples with steatohepatitis, and five samples with cirrhosis) were analyzed at 10-μm lateral resolution. A total of 24 individual lipid species, primarily neutral lipids, were identified (22 TGs and two phospholipids). In samples with a low level of steatosis, TGs accumulated around the pericentral zone. In all samples, TGs with different degrees of side-chain saturation and side-chain length demonstrated differential distribution. Furthermore, hepatocytes containing macro lipid droplets were highly enriched in fully saturated triglycerides. This enrichment was also observed in areas of hepatocyte ballooning in samples with steatohepatitis and cirrhosis. In conclusion, macro lipid droplets in NAFLD are enriched in fully saturated triglycerides, indicating a possible increase in de novo lipogenesis that leads to steatohepatitis and cirrhosis. 
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Introduction
As the global prevalence of obesity increases, the incidence of metabolic syndrome (abdominal obesity, hypertension, dyslipidemia, and hyperinsulinemia) increases. It is believed that the first step towards developing insulin resistance and metabolic syndrome is associated with the accumulation of lipids in non-adipose tissues (steatosis). In the livers of healthy patients with no significant alcohol consumption, the abnormal accumulation of triacylglycerides (triglycerides, TGs) and diacylglycerides (diglycerides, DAGs) is termed nonalcoholic fatty liver disease (NAFLD). NAFLD is a chronic condition and is estimated to affect one fourth of the global population [1] . It describes a spectrum of conditions ranging from simple steatosis (SS) to the more severe progressions of non-alcoholic steatohepatitis (NASH) and liver cirrhosis [2] . NASH is now one of the leading causes of liver cirrhosis in adults worldwide, and in the USA, NASH is the second leading etiology of liver disease among adults awaiting liver transplantation [3] . In addition, liver steatosis in donor grafts causes ischemia-reperfusion injury, and grafts with high levels of steatosis are often excluded from the donor pool [4] . Histologically, the liver is composed of thousands of hexagonal lobules, the liver's smallest functional units. At the periphery of each lobule, portal triads supplying the nutrientrich blood from the portal veins and the oxygen-rich blood from the hepatic arteries join to form small blood vessels called sinusoids that drain into a central hepatic vein. Despite the morphologically homogeneous appearance of the hepatocytes supplied by this vascular structure, the human liver exhibits a functional zonation where hepatocytes in the periportal zone (zone 1), midzone (zone 2), and pericentral zone (zone 3) differ in their metabolic functions and capacities [5] . Liver zonation or hepatic zonation has been described for many metabolic processes including carbohydrate, ammonia, xenobiotic, and more recently fatty acid metabolisms [6] . Two patterns of hepatic steatosis are recognized: microvesicular steatosis, where the cytoplasm is replaced by small lipid droplets that do not displace the nucleus; and macrovesicular steatosis, where the cytoplasm is replaced by a large single lipid droplet that displaces the nucleus to the edge of the cell.
TGs are the main lipid component of the liver in NAFLD. Liver TG synthesis utilizes free fatty acids (FFAs) from adipose tissue, diet, and de novo lipogenesis (DNL). Approximately 60% of all fatty acids stored in the fatty liver originate from the adipose tissue [7] . Recent studies have suggested that the formation of lipid droplets and the accumulation of TGs may be protective against lipotoxic lipid species [8] . Saturated fatty acids (SFAs), on the other hand, have been shown to be toxic to many cell types in culture [9] [10] [11] [12] [13] . Their toxicity, however, is significantly reduced when cosupplemented with unsaturated fatty acids because the latter promote the channeling of SFAs into triglyceride storage [11] . While adipose tissue is the main source of FFAs, DNL is thought to play a major role in the development of NAFLD. Individuals with NAFLD have an increased rate of DNL and higher levels of saturated fatty acids when compared to controls [14] . When comparing subjects with high liver fat levels to those with low liver fat, DNL was the only source of FFAs displaying a statistically significant threefold increase [14] .
The suspected role of different lipid species in the pathogenesis of NAFLD has led to the study of their identity and regional distribution across the spectrum of the disease [15] [16] [17] [18] [19] . Previously, Debois et al. utilized cluster TOF-SIMS imaging to study distribution of different lipid species including TGs in normal and fatty human livers. While successful in demonstrating lipid zonation and macrovesicular enrichment of TGs and DAGs, MS lipid identification was obscured by in-source fragmentation [15] .
In this study, we utilize imaging mass spectrometry (IMS) [20] [21] [22] to image the distribution of TGs in normal and NAFLD human livers. The goal is to study the triglyceride distribution of human liver samples with NAFLD, and whether specific TG species correlate with the histopathological features of NAFLD. Specifically, wither macro and micro lipid droplets have a different TG content. Previous work employing IMS in fatty liver disease studies has focused on phospholipid profiling [16, 18] , small metabolite imaging [23] , and some work showing triglyceride distribution in a mouse model [24] . Few studies have been performed with human samples or targeting TGs specifically. This was due to a lack of MALDI IMS sample preparation method sensitive and/or selective enough to detect a broad range of TGs from tissue sections with resolution fine enough to discriminate relatively small histopathological features (i.e., individual lipid droplets) from tissue. The recently described use of sodium-doped gold-assisted LDI IMS (AuLDI IMS) bridges this gap in triglyceride analysis from tissue sections [25] . This technique specifically favors the detection of sodiated species, greatly enhancing the sensitivity in the detection of TGs in tissue, and is capable of high IMS spatial resolution (< 15 μm spot-to-spot) [26] . To achieve this higher specificity and sensitivity for the detection of TG molecules, the tissue sections are first treated by depositing a carbonate buffer and sodium acetate solution followed by covering the salt layer with a thin layer of gold to achieve the UV absorption required for TG desorption; this increases the specificity for TG molecules at the price of fewer MS signals compared to conventional MALDI methods [25] .
Materials and methods

Study sample and tissue procurement
Twenty samples previously scored by a pathologist according to the NAFLD Activity Score were obtained from the McGill University Health Center Liver Disease Biobank [27] . These samples included four groups: five normal livers, five livers with SS, five livers with NASH, and five livers with cirrhosis. Samples in the normal group were obtained from patients undergoing liver resection for different etiologies. The samples with SS and steatohepatitis were obtained from livers with NAFLD which were deemed unsuitable for transplantation following histopathological examination during organ procurement. Finally, the samples with cirrhosis were obtained from explanted grafts with cirrhosis secondary to NAFLD following liver transplantation. Informed consent was obtained from all patients through the McGill University Health Center Liver Disease Biobank. The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the research ethics board of the McGill University Health Centre. Surgical specimens were procured and released to the Biobank immediately after clearance from the pathologist. Review of charts confirmed no history of excessive alcohol consumption or concurrent liver disease. The specimens were flash frozen within 30 min of resection in the normal group and 120 min in all the other groups.
Tissue preparation and cryosectioning of liver samples
Four samples, each representing one grade of the disease (n = 20 total), were embedded in a block of optimal cutting temperature compound (OCT) in a circular fashion to produce five OCT blocks. This allowed for simultaneous sectioning of more than one sample. Sectioning was accomplished at 20 μm with a Leica CM 3050 cryostat (Leica Microsystems GmbH, Wentzler, Germany) at a sample temperature of − 15°C and chamber temperature of − 26°C. For IMS, sections were mounted on a chromium-gold-coated glass slides prepared in-house using a Cressington 308R sputter coater (Ted Pella Inc., Redding, CA). Mirrored serial sections were also obtained and mounted on glass slides for hematoxylin and eosin (H&E) staining. Sections were stained following standard H&E protocol and digitally scanned at × 20 magnification (corresponding to a 0.454-μm pixel resolution).
Sodium salt deposition and gold sputtering
After desiccation of the IMS slides for 20 min in a vacuum pump desiccator, sodium salt was deposited, followed by gold sputtering as detailed in Dufresne et al. [25] . Briefly, an aqueous solution of carbonate buffer (pH 10.3) at 85 mM and sodium acetate (NaAc) at 250 mM in a 1:1 ratio was Data are presented as mean ± SD. Fibrosis is represented by the mode of individual sample score NASH, non-alcoholic steatohepatitis 
AuLDI IMS parameters
IMS data were acquired at 10-μm spatial resolution in the reflectron geometry using a MALDI-TOF/TOF ultrafleXtreme mass spectrometer equipped with a SmartBeam-II Nd:YAG/355-nm laser operating at a repetition rate of 1 kHz using the Bminimum^laser setting that is estimated to be 15 μm in diameter (Bruker Daltonics, Billerica, MA). flexControl 3.4 and flexImaging 4.0 were used to perform and display IMS data acquisition and results, respectively (Bruker Daltonics, Billerica, MA). All instrumental parameters (source voltages, laser energy, delayed extraction parameters, etc.) were optimized for maximum mass resolution and signal-to-noise ratio within the 700-900 m/z range, with the acceleration voltage set to 25 kV.
Processing IMS data, statistical analysis, and imaging output
Raw IMS data were first internally calibrated using gold isotopic peaks using the flexAnalysis Batch Process software (Bruker Daltonics, Billerica, CA). Next, the calibrated data was exported into the common imzML format using flexImaging 4.1 (Bruker Daltonics, Billerica, CA) then preprocessed and analyzed using the Cardinal package in R [28] , which involved peak picking of the spectra with a S/N threshold of 3 and a minimum peak appearance threshold of 5%. Unsupervised clustering was performed with the Cardinal package in R using spatially aware k-means clustering and the spatial shrunken centroids method [28] [29] [30] .
Results
Study cohort and histopathologic assessment
The 20 samples obtained from the Liver Disease Biobank were scored by a pathologist according to the NAFLD Activity Score (NAS) [27] . Normal livers were obtained from patients undergoing liver resection for various indications (n = 5). Livers with simple steatosis (n = 5), steatohepatitis (n = 5), and cirrhosis (n = 5) were obtained from diseased donors with no significant history of alcohol consumption or concurrent liver disease ( Table 1) .
Distribution of triglycerides detected by AuLDI IMS in NAFLD human liver sections
Accumulation of triglycerides (TGs) within hepatocytes is the hallmark of NAFLD. Chemically, TGs have a structure of three fatty acyl chains with ester linkages to a glycerol backbone (see Electronic Supplementary Material (ESM) Fig. S1 ). The diversity of triglyceride species arises from variation of both the length of the fatty acyl chains and the number of unsaturations (C=C double bonds) along the same fatty acid chains. Mass spectrometry detects these changes in fatty acyl chain unsaturation and length as changes in the mass-to-charge (m/z) ratio of the individual TGs. Thus, IMS is well suited to determine the specific TG content of lipid droplets in cells. Utilizing the previously described AuLDI sample preparation for enhanced IMS of triglycerides [25] , we have analyzed all samples and identified a total of 24 lipid species (22 TGs and 2 phospholipids, Table 2 ) from the liver sample set. Typical AuLDI MS spectra of TGs acquired from NASH samples are observed in ESM Fig. S2 . Observed TG fragment ions obtained by tandem MS (MS/MS) are listed in ESM Table S1 . An example TG MS/MS spectrum (TG 53:3, m/z 879.7) is also presented in ESM Fig. S1 .
Triglyceride signals co-localized with both macro and micro lipid droplets and followed a distribution similar to that seen for steatosis when assessing H&E liver sections. In samples with steatosis < 5%, triglycerides were accumulating around the pericentral zone (Fig. 1) .
However, when analyzing a sample with simple steatosis, TGs with different degrees of side-chain saturation and side-chain length demonstrated differential distribution. In one liver sample with simple steatosis, the periportal zone hepatocytes were enriched with TG48:2, TG48:3, and TG50:3, while the pericentral zone contained TGs with longer side-chain length including TG52:1, TG54:2, and TG54:3 (Fig. 2) . Spatially aware clustering analysis of this individual sample resulted in five clusters that distinctively separated the pericentral, mid, and periportal zones (Fig. 3, segments 3, 4 , and 5, respectively). The pericentral zone in this sample showed enrichment in TGs with side-chain length ranging between 52 and 54 as compared to 48-52 in the periportal zone (Fig.  3) . This differential zonation of TG species was observed in each sample individually. However, the zonation differed between samples, and no specific TG species was found to be preferentially distributed to a specific zone when accounting for all samples in our dataset.
Hepatocytes with macrovesicular steatosis are enriched in saturated triglycerides
Macrovesicular steatosis with hepatocytes distended by a single lipid droplet that displaces the nucleus to the side is associated with advanced disease and the development of inflammation and fibrosis [31] . It is also associated (when severe) with worse outcomes after liver surgery [4, 32] . In all studied samples, hepatocytes containing macro lipid droplets were highly enriched in fully saturated TGs (Fig. 4) . These clusters of macrovesicular hepatocytes were sometimes surrounded with microvesicular steatosis that were enriched in monounsaturated TGs (Figs. 5a and 3 segments 1 and 2 and ESM Fig. S3 ). The only other histopathological feature associated with enrichment of saturated TGs was hepatocyte ballooning in NASH and cirrhotic samples. In cirrhotic samples, regenerative nodules had very low TG signal with areas of hepatocyte ballooning at the periphery and the center. These hepatocytes with ballooning showed a TG signal rich in saturated TGs similar to that of an area of macrovesicular steatosis in a liver with simple steatosis (Fig. 5b) . This suggests that areas of hepatocyte ballooning were originally hepatocytes with macrovesicular steatosis.
Identified TG species and their corresponding signal intensities divided according to the study groups are demonstrated in Fig. 6 .
Discussion
The goal of this study was to determine the distribution of TGs in normal, steatotic, and cirrhotic human liver samples, specifically, if different TG species correlate with histopathological features of NAFLD. First, we determined the distribution of TGs in normal and mildly steatotic tissue (Figs. 1 and 2 ) and further delineated the liver's zonation in early disease by TG's distribution (Fig.  2) in concert with histopathological examination. Following the novel characterization of TG distribution in normal liver tissue, we demonstrated for the first time that hepatocytes with macrovesicular steatosis are highly enriched in TGs with fully saturated fatty acid side chains (Fig. 3) . Macrovesicular steatosis has been associated with worse outcomes following ischemia reperfusion injury (IRI) in liver transplantation and major liver resections [32, 33] . In a systematic review of the impact of hepatic steatosis on IRI, transplanted livers with > 30% macrosteatosis were associated with liver function derangement and reduced survival while microvesicular steatosis did not influence outcome. While IRI in steatotic livers could be partially contributed to microcirculatory dysfunction, it can also be partially explained by increased sensitivity to reactive oxygen species and impaired endoplasmic reticulum function [34] .
TG synthesis utilizes FFAs from the adipose tissue, diet, and through de novo lipogenesis. While the adipose tissue contributes the majority of FFAs in the liver [7] , tracer studies on matched controls with or without hepatic steatosis showed no difference in the adipose tissue contribution to the hepatic lipid pool [14] . However, DNL was threefold greater in subjects with NAFLD compared to that in controls [14] . (DNL is the process of which hepatocytes synthesize fatty acids from acetyl-CoA subunits.) These are more commonly produced through carbohydrate catabolism. The enrichment of macrovascular hepatocytes with saturated TGs points towards de novo lipogenesis given that the primary products of DNL are saturated fatty acids. Saturated fatty acids have been shown to be cytotoxic to many cell types in culture [9] [10] [11] [12] [13] . They have also been noted to increase the saturation of membrane phospholipids, causing the activation of the unfolded protein response, endoplasmic reticulum stress, and apoptosis [35] . SFAs promote reactive oxygen species accumulation and affect mitochondrial metabolism [35] . Further, it has been suggested that insulin resistance in the liver is associated with increased concentration of saturated TGs [36] , indicating they induce negative metabolic effects in both free forms and incorporated in larger molecular scaffolds. In our data, saturated TGs were highly concentrated in hepatocytes with macrovesicular steatosis. This might reflect a protective mechanism against high levels of SFAs. This temporary protective measure however does not prevent stored TGs from serving as a source of lipotoxic lipid species when hydrolyzed. Areas of hepatocyte ballooning in our data showed a TG signature enriched in saturated TGs, similar to areas of macrovesicular steatosis (Fig. 5 ). This suggests that macrovesicular steatosis eventually undergoes ballooning, pointing to long-term toxicity. The cross-sectional nature of our study prevents a longitudinal look into the role of macrovesicular steatosis and saturated TGs in the development of NASH. In human livers with total steatosis < 5%, TGs were accumulated around the pericentral zone. This is consistent with the functional properties of the pericentral zone, which exhibits higher levels of lipogenesis compared to periportal zone. In samples with simple steatosis and NASH, different patterns of pericentral, periportal, and panacinar distributions were noted. Of interest, many livers had TGs with differential distribution around the central vein or portal triad (Fig. 2) . We suspect this to be due to alteration in the source of fatty acids in which pericentral hepatocytes have a higher level of de novo synthesis of fatty acids compared to those in the periportal zone; however, this remains to be further investigated.
While our findings are from a small cohort, it provides a new understanding of macrovesicular steatosis; the enrichment of macro lipid droplets with saturated TGs perhaps reflects an increase in de novo lipogenesis and a protective mechanism against SFAs during a time of overabundance. These hepatocytes might represent a metabolic burden when hydrolyzed and an area where apoptosis and inflammation might follow. Further profiling of TG distribution in larger cohorts and studies of the role of macrovesicular steatosis and saturated TGs in the development of NASH are required to confirm these results.
